Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flecainide

Next Previous
X
Search
Drug Profile

Flecainide

Alternative Names: Almarytm; Apocard; Aristocor; Diondel; Flecaine; Flecainide acetate; Tambocor

Latest Information Update: 02 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator 3M Pharmaceuticals
  • Developer 3M Pharmaceuticals; Eisai Co Ltd
  • Class Benzamides; Class Ic antiarrhythmics; Piperidines; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Arrhythmias; Paroxysmal atrial fibrillation; Paroxysmal atrial flutter; Paroxysmal supraventricular tachycardia; Ventricular arrhythmias; Ventricular tachycardia

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 05 Aug 2016 Meda has been acquired by Mylan
  • 26 Jun 2015 Launched for Paroxysmal supraventricular tachycardia, paroxysmal atrial fibrillation, ventricular tachycardia and paroxysmal atrial flutter (In children) in Japan (PO)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top